ABPI have been denied the opportunity to legally challenge incorporation of the £20 million budget impact test being incorporated into NICE assessments.
ABPI have been denied the opportunity to legally challenge incorporation of the £20 million budget impact test being incorporated into NICE assessments.
The publication of the first three EU Joint Clinical Assessments (JCAs) provides the first opportuni...
Read morePricing strategies rarely fail because of one decision. More often, price potential is gradually ero...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch